SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech insider buys

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (190)1/26/2008 5:30:30 AM
From: Icebrg   of 213
 
No, it isn't,

but the interesting point here is: Why do it at all? Stoll was just the other day "awarded" 200.000 options exercisable at 0,54. So, there is definitively no reason for him to buy an additional 20.000 shares from the open market at more or less the same price.

So, the purchases are interesting not because of the amounts involved, but rather the message he might be trying to send to shareholders and investors.

Stoll comes across as a rather conservative type of person, so I don't look at this as a move in desperation to try to create the idea that the company is doing better than it is.

On the other hand, they are (as always) about to run out of money.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext